Showing results (101-110 of 120) with videos related to
Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2013
Structural model for the protein-translocating element of the twin-arginine transport systemFernanda Rodriguez, Sarah L Rouse, Claudia E Tait, et al.Proceedings of the National Academy of Sciences of the United States of America|September 14, 2016
A C-terminal amphipathic helix is necessary for the in vivo tubule-shaping function of a plant reticulonEmily Breeze, Natasha Dzimitrowicz, Verena Kriechbaumer, et al.Cancers|July 29, 2023
Completion of Genetic Testing and Incidence of Pathogenic Germline Mutation among Patients with Early-Onset Colorectal Cancer: A Single Institution AnalysisMichael H Storandt, Kara R Rogen, Anushka Iyyangar, et al.International Journal of Cancer|May 16, 1996
Potent anti-tumor effects of an anti-CD24 ricin A-chain immunotoxin in vitro and in a disseminated human Burkitt's lymphoma model in SCID miceR Schnell, A A Katouzi, C Linnartz, et al.Chemical Reviews|March 1, 2018
Perturbations of Native Membrane Protein Structure in Alkyl Phosphocholine Detergents: A Critical Assessment of NMR and Biophysical StudiesChristophe Chipot, François Dehez, Jason R Schnell, et al.Cancer Research|August 15, 2008
Effects of the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 on the tumor vasculature: implications for clinical imagingChristian R Schnell, Frédéric Stauffer, Peter R Allegrini, et al.Nuklearmedizin. Nuclear Medicine|February 4, 2010
Development of anti-CD30 radioimmunoconstructs (RICs) for treatment of Hodgkin's lymphoma. Studies with cell lines and animal studiesMarkus Dietlein, S M Börner, T Fischer, et al.Journal of the American Chemical Society|March 11, 2026
Unnatural Cytosine Analogs Potentiate a Customizable, Enzymatic Method for Integrated Epigenetic and Four-Base Genetic SequencingChristian E Loo, Jared B Parker, Aleksia Barka, et al.Leukemia & Lymphoma|February 1, 1997
A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin's lymphomaA Engert, R Schnell, F Küpper, et al.Blood|January 15, 1997
A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphomaA Engert, V Diehl, R Schnell, et al.Pageof 12